Reni M. Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing? World J Gastroenterol 2010; 16(39): 4883-4887 [PMID: 20954273 DOI: 10.3748/wjg.v16.i39.4883]
Corresponding Author of This Article
Michele Reni, MD, Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, 20132-Milan, Italy. reni.michele@hsr.it
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/